Relic Pharma Limited

Provides share broking services with registered office in Mumbai, Maharashtra.

1995 | Mumbai, Maharashtra (India) | Active
Last Updated:

Relic Pharma Profile

Key Indicators

  • Authorised Capital ₹ 3.25 Cr
  • Paid Up Capital ₹ 1.00 Cr
  • Company Age 30 Year, 12 Days
  • Last Filing with ROC 31 Mar 2023
  • Revenue Growth -100.00%
  • Profit Growth -189.29%
  • Ebitda 24.51%
  • Net Worth -0.11%
  • Total Assets -0.07%

About Relic Pharma

Relic Pharma Limited (RPL) is a Public Limited Indian Non-Government Company incorporated in India on 04 May 1995 and has a history of 30 years. Its registered office is in Mumbai, Maharashtra, India.

The Company is engaged in the Financial Services Industry.

The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.25 Cr and a paid-up capital of Rs 1.00 Cr, as per Ministry of Corporate Affairs (MCA) records.

Hemant Choksey, Baijoo Raval, and Uday Raval serve as directors at the Company.

Company Details

  • Location

    Mumbai, Maharashtra, India

  • Telephone

    +91-XXXXXXXXXX

  • Email Address

  • Website

  • Social Media

Corporate Identity Details

  • CIN/LLPIN

    U67120MH1995PLC088000

  • Company No.

    088000

  • Company Classification

    Public Limited Indian Non-Government Company

  • Incorporation Date

    04 May 1995

  • Date of AGM

    30 Sep 2023

  • Date of Balance Sheet

    31 Mar 2023

  • Listing Status

    Unlisted

  • ROC Code

    Roc Mumbai

Industry

Financial Services
Company report

Relic Pharma Limited

Explore comprehensive data for Relic Pharma Limited, including financials, compliance details, shareholding patterns, and litigation history.

Who are the key members and board of directors at Relic Pharma?

Board Members (3)

NameDesignationAppointment DateStatus
Hemant Choksey Country flag representing In Director 19-Apr-2014Current
Baijoo Raval Country flag representing In Director 04-May-1995Current
Uday Raval Country flag representing Us Director 04-May-1995Current

Financial Performance of Relic Pharma.

Relic Pharma Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 100% decrease. The company also saw a substantial fall in profitability, with a 189.29% decrease in profit. The company's net worth dipped by a decrease of 0.11%.

Relic Pharma revenue growth over time
Relic Pharma profit and loss trends over time
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
-100.00%
Revenue from Operations
Total Assets
-0.07%
Profit or Loss
-189.29%
Net Worth
-0.11%
EBITDA
24.51%

What is the Ownership and Shareholding Structure of Relic Pharma?

In 2021, Relic Pharma had a promoter holding of 99.93% and a public holding of 0.07%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Indicator graph

Charges (Loans)

Placeholder for charges-related data

There are no open charges registered against the company as per our records.

How Many Employees Work at Relic Pharma?

Unlock and access historical data on people associated with Relic Pharma, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee growth trends for Relic Pharma Limited

Deals i

Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Relic Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Relic Pharma's trajectory.

Rating

Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Latest Updates, News, and FAQs on Relic Pharma

Recent activity within the organization

  • Annual General Meeting

    Relic Pharma Limited last Annual general meeting of members was held on 30 Sep 2023 as per latest MCA records.

  • Balance Sheet

    Relic Pharma Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Mumbai.

  • Director Appointment

    Hemant Kantilal Choksey was appointed as a Director was appointed as a Director on 19 Apr 2014 & has been associated with this company since 11 years 27 days .

  • Director Appointment

    Baijoo Madhusudan Raval was appointed as a Director was appointed as a Director on 04 May 1995 & has been associated with this company since 30 years 12 days .

  • Director Appointment

    Uday Madhusudan Raval was appointed as a Director was appointed as a Director on 04 May 1995 & has been associated with this company since 30 years 12 days .

  • Company Incorporation

    Relic Pharma Limited was registered on 04 May 1995 with Roc Mumbai & aged 30 years 12 days as per MCA records.

Frequently asked questions

  • What is the Incorporation or founding date of Relic Pharma Limited?

    Relic Pharma Limited was incorporated on 04 May 1995.

  • What is authorized share capital and paid-up capital of Relic Pharma Limited?

    The authorized share capital of Relic Pharma Limited is ₹ 3.25 Cr and paid-up capital is ₹ 1.00 Cr.

  • Who are the current board members & directors of Relic Pharma Limited?

    Currently 3 directors are associated with Relic Pharma Limited.

    • Hemant Kantilal Choksey
    • Baijoo Madhusudan Raval
    • Uday Madhusudan Raval

  • What is the registered address of Relic Pharma Limited?

    As per Ministry of Corporate Affairs (Mca), the registered address of Relic Pharma Limited is J-Block Bhangwadi Shopping Centre Kalbadevi Road India, Mumbai, Maharashtra, 400002.

  • What is the corporate identification number (CIN) and company number of Relic Pharma Limited?

    The corporate identification number (CIN) of Relic Pharma Limited is U67120MH1995PLC088000 and the company number is 088000 as per Ministry of Corporate Affairs (MCA).

  • What has been the recent revenue trend for Relic Pharma Limited?

    According to the financial reports for the fiscal year 2023, the revenue trend for Relic Pharma Limited has fallen by -100.00%.

  • What change has been observed in the net worth of Relic Pharma Limited, and by what percentage?

    The financial reports for the fiscal year 2023 indicates that The net worth of Relic Pharma Limited has experienced an downturn of -0.11%.

  • When was the last Balance Sheet of Relic Pharma Limited filed with the ROC?

    The most recent Balance Sheet for Relic Pharma Limited was filed with the ROC on 31 Mar 2023.

Unlock Business Insights – Explore Instantly!

Search company & director profiles for free and gain access to critical business data.

  • 3.1M+ Companies
  • 15M+ Legal Cases
  • 525K+ Credit Ratings
  • 5.8M+ Directors & KMP
  • 750K+ Regulatory Alerts
  • 1.1M+ Companies' Financial Records
Start Free Trial

People also Viewed

Similar Companies Based on Brokerage & Trading Services